LIDDS
0.02 SEK
-33.14 %
Less than 1K followers
LIDDS
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-33.14 %
-47.73 %
-52.67 %
-62.05 %
-74.44 %
-83.51 %
-98.50 %
-99.83 %
-99.76 %
LIDDS is a pharmaceutical company. The company develops pharmaceutical products based on a patented and clinically tested drug delivery technology. The properties of the products form the basis of the LIDDS technology platform for the development of injectable pharmaceutical products. LIDDS is the abbreviation for Local Intelligent Drug Delivery System, and the company is headquartered in Uppsala.
Read moreMarket cap
3.14M SEK
Turnover
34.07K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
19.2
2026
Annual report '25
28.5
2026
Interim report Q1'26
28.5
2026
General meeting '26
All
Press releases
ShowingAll content types
LIDDS AB (publ) proposes that the general meeting, as well as the second control meeting, resolve on voluntary liquidation and the delisting of the company’s shares
Announcement from extraordinary general meeting in LIDDS AB (publ) held on 18 December 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools